By Max Schindler
With dozens of Israeli growers and manufacturers receiving licenses to produce medicinal cannabis, bureaucratic roadblocks and ministerial infighting could leave the marijuana to eventually rot or be sold on the black market, costing companies more than NIS 1 billion.
Last week, the cabinet hinted that it would approve exports of medicinal cannabis during the 2019 state budget vote, only to dash hopes by leaving the measure out.
The government reportedly told Israeli medicinal marijuana companies that their exports would be approved by 2018, according to industry employees. That persuaded the companies to embark on multi-billion shekel investments, some of which could now be in jeopardy.
Read more at The Jerusalem Post